At Nouvogenes Therapeutics, we are driven by a bold vision: to transform the treatment of chronic diseases through precision gene editing. Using cutting-edge CRISPR technology, our clinical-stage therapies target the root cause of conditions, offering not just incremental improvements, but the possibility of a one-time treatment that could free patients from a lifetime of care, complications, and clinical dependency. With a growing pipeline of gene therapy candidates, we are committed to advancing science that restores health, reduces suffering, and redefines what’s possible for patients.
Company Details
- Employees
- 1
- Founded
- -
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.nouvogenes.com
Nouvogenes Therapeutics Co. Ltd. Questions
Nouvogenes Therapeutics Co. Ltd.'s website is https://www.nouvogenes.com
Nouvogenes Therapeutics Co. Ltd.'s LinkedIn profile is https://www.linkedin.com/company/nouvogenes-therapeutics-co-ltd
Nouvogenes Therapeutics Co. Ltd. has
1 employees.
View email and phone details for 1
employees at Nouvogenes Therapeutics Co. Ltd..
Nouvogenes Therapeutics Co. Ltd.'s industry is
Pharmaceutical Manufacturing
Nouvogenes Therapeutics Co. Ltd.'s top competitors are
Gala Pharma Sa De Cv,
Aop Health - Benelux,
Biotech01,
Mineed Technology Co., Ltd.,
Thought Leader Select,
Buzz Health & Life Sciences,
Bio-Rep Animal Health,
Noyangen,
Remedco Ag,
Testing.
Nouvogenes Therapeutics Co. Ltd.'s categories are Pharmaceutical Manufacturing
Nouvogenes Therapeutics Co. Ltd.'s founding year is 2025
